Nanodiamond based surface modified screen-printed electrodes for the simultaneous voltammetric determination of dopamine and uric acid

Sensitive sensing platform based on Co, Mo doped electrospun nanofibers for simultaneous electrochemical detection of dopamine and uric acid

Abnormal levels of dopamine (DA) and uric acid (UA) in the human body are valuable indicators for monitoring human health, as they are associated with certain diseases. Therefore, it is crucial to develop sensitive and simultaneous analytical techniques for DA and UA in diagnosing the related diseases. Herein, the Co- and Mo- doped carbon nanofibers (Co, Mo@CNFs) electrochemical biosensor was developed successfully for the sensitive and accurate simultaneous detection of DA and UA. A straightforward electrospinning technique followed by a carbonization process was employed for the synthesis of Co, Mo@CNFs, and the encapsulation of Co and Mo within CNFs served to not only prevent nanoparticle agglomeration, thus providing more active sites, but also to facilitate rapid electron transfer. By incorporating Co and Mo into CNFs, the electrocatalytic activity of the modified electrode was greatly improved due to the beneficial conductivity and synergistic effects of transition metals. This enhancement effectively addressed issues such as the overlapping anodic peaks that occur when DA and UA are oxidized concurrently. Due to the mentioned synergistic contributions, the modified Co, Mo@CNFs electrode (Co, Mo@CNFs/GCE) achieved remarkable sensitivity for the simultaneous detection of DA and UA, while also exhibiting strong anti-interference ability. The detection limits for DA and UA were 2.35 nmol L-1 and 0.16 μmol L-1, respectively. We applied the developed Co, Mo@CNFs/GCE electrochemical biosensor to detect DA and UA in 50-fold diluted serum and urine samples. The results affirm the biosensor's reliability and precision. Moreover, the developed Co, Mo@CNFs/GCE biosensor demonstrated excellent performance in simultaneously detecting DA and UA, providing an efficient and dependable detection approach for clinical diagnosis and bioanalysis.

Non-toxic flexible screen-printed MWCNT-based electrodes for non-invasive biomedical applications

Here, a non-toxic, flexible, low-cost, and disposable multiwalled carbon nanotube (MWCNT)-based screen-printed electrode (SPE) was developed for non-invasive health monitoring applications. A novel MWCNT-based conductive paste formulation was prepared and optimized for printing SPEs using a computer numerical control (CNC)-made stencil. The electrodes were electrochemically characterized and subjected to physical stress to investigate their mechanical durability in extreme situations such as heavy exercise. The reproducibility of the fabrication approach and the stability of the electrodes were also demonstrated. The electrochemical performance of the electrodes was tested with first dopamine (DA) and then glucose. The SPE displayed a linear response in the DA concentration range of 5-500 μM with a limit-of-detection (LOD) of 0.87 μM. Detection of glucose was carried out based on electrochemical-enzymatic redox cycling in artificial sweat; wherein the flexible SPE-based biosensor exhibited a linear response, particularly up to 1 mM with an LOD of 31.7 μM. It is likely that the high sensitivity was achieved due to the large surface-to-volume ratio of MWCNTs and micro/nanoporous network morphology of the electrode surface which was observed in scanning electron microscopy (SEM). Cytotoxicity tests confirmed that the flexible MWCNT-SPEs are non-toxic and therefore safe for non-invasive health monitoring. As a result, the electrodes displayed excellent electrochemical behavior and are expected to contribute to wearable sensor technology due to features such as high stability, sensitivity, flexibility, and non-toxicity.

A disposable sensor based on one-pot synthesized tungsten oxide nanostructure-modified screen printed electrodes for selective detection of dopamine and uric acid

Here, screen-printed carbon electrodes (SPCEs) were modified with ultrafine and mainly mono-disperse sea urchin-like tungsten oxide (SUWO3) nanostructures synthesized by a simple one-pot hydrothermal method for non-enzymatic detection of dopamine (DA) and uric acid (UA) in synthetic urine. Sea urchin-like nanostructures were clearly observed in scanning electron microscope images and WO3 composition was confirmed with XRD, Raman, FTIR and UV-Vis spectrophotometer. Modification of SPCEs with SUWO3 nanostructures via the drop-casting method clearly reduced the Rct value of the electrodes, lowered the ∆Ep and enhanced the DA oxidation current due to high electrocatalytic activity. As a result, SUWO3/SPCEs enabled highly sensitive non-enzymatic detection of DA (LOD: 51.4 nM and sensitivity: 127 µA mM-1 cm-2) and UA (LOD: 253 nM and sensitivity: 55.9 µA mM-1 cm-2) at low concentration. Lastly, SUWO3/SPCEs were tested with synthetic urine, in which acceptable recoveries for both molecules (94.02-105.8%) were obtained. Given the high selectivity, the sensor has the potential to be used for highly sensitive simultaneous detection of DA and UA in real biological samples.

Nano-modified screen-printed electrode-based electrochemical immunosensors for oral cancer biomarker detection in undiluted human serum and saliva samples

This proposed work reports the development of in-house made conductive ink-based screen-printed electrodes (SPEs) for label-free detection of oral cancer biomarkers. Carbon ink synthesis includes graphite powder, gum arabic, and water. The selectivity test of the fabricated SPE involves immobilizing antibodies specific to biomarkers and challenges with redox-active interference, other serum molecules, and non-target biomarkers. Three different biomarkers, cytokeratin-19 fragment (CYFRA 21-1), interleukin 8 (IL-8), and tumor protein p53 (TP-53), act as target entities for the detection of oral cancer in patients' samples (serum, N = 28, and saliva, N = 16) at an early stage. The standard technique enzyme-linked immunosorbent assay (ELISA) was employed to estimate the concentration of the biomarkers in serum and saliva samples. SPEs contain amine (-NH2) functional groups involved in covalent bonding with the carboxyl (-COOH) groups of antibody molecules. These immunosensors exhibited remarkably lower detection limits of 829.5 pg mL-1, 0.543 pg mL-1, and 1.165 pg mL-1, and excellent sensitivity of 0.935 μA mL pg-1 cm-1, 0.039 μA mL pg-1 cm-1, and 0.008 μA mL pg-1 cm-1 for CYFRA 21-1, IL-8, and TP-53 biomarkers, respectively. This sensing platform does not require any functionalization for biomolecule immobilization. Thus, it is a cost-effective, disposable, flexible, miniaturized, and sensitive strip to detect oral cancer biomarkers.

Ultra-Fast Impedimetric Immunoassay for Detection of Streptococcus agalactiae Using Carbon Electrode with Nanodiamonds Film

This publication presents the results of work on the development of a quick and cheap electrochemical immunosensor for the diagnosis of infections with the pathogen Streptococcus agalactiae. The research was carried out on the basis of the modification of the well-known glassy carbon (GC) electrodes. The surface of the GC (glassy carbon) electrode was covered with a film made of nanodiamonds, which increased the number of sites for the attachment of anti-Streptococcus agalactiae antibodies. The GC surface was activated with EDC/NHS (1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide/N-Hydroxysuccinimide). Determination of electrode characteristics after each modification step, performed using cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS).

Recent Development of Nano-Carbon Material in Pharmaceutical Application: A Review

Carbon nanomaterials have attracted researchers in pharmaceutical applications due to their outstanding properties and flexible dimensional structures. Carbon nanomaterials (CNMs) have electrical properties, high thermal surface area, and high cellular internalization, making them suitable for drug and gene delivery, antioxidants, bioimaging, biosensing, and tissue engineering applications. There are various types of carbon nanomaterials including graphene, carbon nanotubes, fullerenes, nanodiamond, quantum dots and many more that have interesting applications in the future. The functionalization of the carbon nanomaterial surface could modify its chemical and physical properties, as well as improve drug loading capacity, biocompatibility, suppress immune response and have the ability to direct drug delivery to the targeted site. Carbon nanomaterials could also be fabricated into composites with proteins and drugs to reduce toxicity and increase effectiveness in the pharmaceutical field. Thus, carbon nanomaterials are very effective for applications in pharmaceutical or biomedical systems. This review will demonstrate the extraordinary properties of nanocarbon materials that can be used in pharmaceutical applications.

Electrochemical Sensor Nanoarchitectonics for Sensitive Detection of Uric Acid in Human Whole Blood Based on Screen-Printed Carbon Electrode Equipped with Vertically-Ordered Mesoporous Silica-Nanochannel Film

Screen-printed carbon electrodes (SPCEs) bear great potential in the detection of biomarker in clinical samples with low sample consumption. However, modification of electrode surfaces to improve the anti-interference ability and sensitivity is highly desirable for direct electroanalysis of whole blood samples. Here, a reliable and miniaturized electrochemical sensor is demonstrated based on SPCE equipped with vertically-ordered mesoporous silica-nanochannel film (VMSF). To achieve stable binding of VMSF and improve the electrocatalytic performance, electrochemically reduced graphene oxide (ErGO) is applied as a conductive adhesion layer, that is in situ reduced from GO nanosheets during fast growth (less than 10 s) of amino groups modified VMSF (NH2-VMSF) using electrochemically assisted self-assembly (EASA). In comparison with bare SPCE, NH2-VMSF/ErGO/SPCE exhibits decreased oxidation potential of uric acid (UA) by 147 mV owing to significant electrocatalytic ability of ErGO. The dual signal amplification based on electrocatalysis of ErGO and enrichment of nanochannels leads to enhanced peak current by 3.9 times. Thus, the developed NH2-VMSF/ErGO/SPCE sensor enables sensitive detection of UA in the range from 0.5 μM to 180 μM with a low limit of detection (LOD, 129 nM, S/N = 3). Owing to good anti-fouling ability and high selectivity of the sensor, direct and rapid detection of UA in human whole blood is realized with very low sample consumption (50 μL).

Applications of electrochemical biosensors based on functional antibody-modified screen-printed electrodes: a review

The detection of biomolecular analytes is of great importance in clinical, environmental, and argo-food areas, among which the electrochemical methodology is attracting much attention. In particular, screen-printed electrode (SPE)-based sensing applications have exhibited potential possibility for on-site detection, especially for fast clinical biomarker detection, since they provide a miniaturized but robust and portable electrode detection system. In this context, we focused on the modification of SPE with functional antibodies to improve the electrochemical detection performance in versatile sensing applications, particularly for COVID-19 detection. These antibodies were immobilized onto the electrode surface via various methodologies, through which the powerful potential from the modification of SPE was revealed. Finally, more novel and excellent works on the biomolecular modification of SPE and the prospects of this technology from its state-of-art status to commercialization are previewed and future perspectives in this field are mentioned.

Screen-printed analytical strip constructed with bacteria-templated porous N-doped carbon nanorods/Au nanoparticles for sensitive electrochemical detection of dopamine molecules

Dopamine (DA) as an important neurotransmitter plays an important role in physiological activities, and its abnormal level can cause diseases such as Parkinson's disease. However, the clinical analysis of DA mainly relies on time-consuming and expensive liquid chromatography and molecular spectrometer. We present here a design and fabrication of inexpensive strip sensor constructed from screen printed electrodes for sensitive and selective detection of DA. The ink used for printing the strips contains Shewanella putrefaciens-templated porous N-doped carbon nanorods (N-doped CN) and Au nanoparticles (Au NPs), in which the N-doping enhances CN's negative charge to electrostatically attract the positively charged DA with strong adsorption for achieving fast electron transfer. Moreover, results indicate that the Au NPs impregnation in N-doped CN renders much more catalytic reaction sites toward DA oxidation current. The strip sensor exhibits high sensitivity for DA detection with a broad linear range of 0.02-700 μM and a low detection limit of 0.007 μM as well as good selectivity and superior flexibility for great potential in wearable applications. The strip sensor further performs an accurate detection of DA in human serum, providing a powerful analytical tool for diagnosis of DA related diseases in clinical analysis.

Conductive Nanodiamond-Based Detection of Neurotransmitters: One Decade, Few Sensors

Nanodiamond (ND) is a class of carbon nanomaterial with covalently connected sp³ carbon atoms in its core and an sp² carbon adorned surface via edge defects or doping. Endogenous chemicals that provoke physiological responses in the human system called neurotransmitters (NTs) have been detected with several sensors with carbon-based nanomaterials. Nanodiamonds (NDs), another class of carbon nanomaterial, have shown the requisite surface area and electrocatalytic activity toward NTs in the past decade. Surprisingly, only a few electrochemical ND based NT sensors are available. This work briefly looked into the performance of the available sensors, NT and ND interactions, and the possible reason for data paucity on the subject matter.

Disposable non-enzymatic electrochemical glucose sensors based on screen-printed graphite macroelectrodes modified via a facile methodology with Ni, Cu, and Ni/Cu hydroxides are shown to accurately determine glucose in real human serum blood samples

A three dimensional (3D) non-enzymatic glucose disposable electrochemical sensor based on screen-printed graphite macroelectrodes (SPEs), modified with nickel hydroxide (Ni(OH)₂/SPE), copper hydroxide (Cu(OH)₂/SPE) and mixed (Ni(OH)₂/Cu(OH)₂/SPE) microstructures were prepared by a facile and cost-effective electrochemical method for the first time. Their morphologies and structures were analyzed by scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDX) and X-ray diffraction (XRD). The electrochemical performances of the modified SPEs were evaluated by cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and amperometric measurements. EIS experiments showed lower charge transfer resistance R_ct values for the modified SPEs, calculated to be 29.24 kΩ, 22.58 kΩ, 13.27 kΩ and 36.48 kΩ for Ni(OH)₂/SPE, Cu(OH)₂/SPE, Ni(OH)₂/Cu(OH)₂/SPE, and SPE, respectively. Under optimal experimental conditions, the results reveal that CV, amperometry and EIS can be readily applied to determine glucose using all of the fabricated sensors, however in terms of an accessible and clinically relevant linear range for the electroanalytical detection of glucose, CV is preferred, where Cu(OH)₂/SPE exhibits the largest linear range from 1 μM to 20 mM (R² = 0.997). In terms of sensitivity and the detection limit however, amperometry appeared to be a better choice of technique, particularly with Ni(OH)₂/Cu(OH)₂/SPE which demonstrated the highest sensitivity of 2029 μA mM^-1 cm^-2 and the lowest detection limit of 0.2 μM (S/N = 3). Excellent selectivity was evident against common interfering species, and it was shown to be possible to obtain satisfactory results in human blood serum samples using the as-fabricated sensors. The low cost of the SPEs, the facile preparation and observed clinically relevant analytical sensitivities and limit of detections towards the sensing of glucose make these screen-printed macroelectrode based electrochemical sensing platforms promising for routine human blood serum glucose analysis.

A novel flow injection amperometric sensor based on carbon black and graphene oxide modified screen-printed carbon electrode for highly sensitive determination of uric acid

A simple, rapid, and cost-effective flow injection amperometric (FI-Amp) sensor for sensitive determination of uric acid (UA) was developed based on a new combination of carbon black (CB) and graphene oxide (GO) modified screen-printed carbon electrode (SPCE). The CB-GO nanocomposites were simply synthesized and modified on the working electrode surface to increase electrode conductivity and enhance the sensitivity of UA determination via the electrocatalytic activity toward UA oxidation. The morphologies and electrochemical properties of the synthesized nanomaterials were investigated through scanning electron microscopy (SEM), transmission electron microscopy (TEM), electrochemical impedance spectroscopy (EIS), and cyclic voltammetry (CV). The modified electrode was incorporated with FI-Amp to improve UA detection's sensitivity, stability, and automation. Some parameters affecting sensitivity were optimized, including pH of the electrolyte solution, applied potential, amount of CB-GO suspension, flow rate, injection volume, and reaction coil length. Using an applied potential of +0.35 V (vs Ag/AgCl), the anodic current was linearly proportional to UA concentration over the range of 0.05-2000 μM with a detection limit of 0.01 μM (3 S/N). Besides, the developed method provides a sample throughput of 25 injections h^-1, excellent sensitivity (0.0191 μA/μM), selectivity, repeatability (RSD 3.1%, n = 7), and stability (RSD 1.08%, n = 50). The proposed system can tolerate potential interferences commonly found in human urine. Furthermore, a good correlation coefficient between the results obtained from the FI-Amp sensor and a hospital laboratory implies that the proposed system is accurate and can be utilized for UA detection in urine samples.

Electrochemical Properties of Screen-Printed Carbon Nano-Onion Electrodes

The properties of carbon nano-onions (CNOs) make them attractive electrode materials/additives for the development of low-cost, simple to use and highly sensitive Screen Printed Electrodes (SPEs). Here, we report the development of the first CNO-based ink for the fabrication of low-cost and disposable electrodes, leading to high-performance sensors. Achieving a true dispersion of CNOs is intrinsically challenging and a key aspect of the ink formulation. The screen-printing ink formulation is achieved by carefully selecting and optimising the conductive materials (graphite (GRT) and CNOs), the polymer binder, the organic solvent and the plasticiser. Our CNO/GRT-based screen-printed electrodes consist of an interconnected network of conducting carbon particles with a uniform distribution. Electrochemical studies show a heterogeneous electron transfer rate constant of 1.3 ± 0.7 × 10^-3 cm·s^-1 and a higher current density than the ferrocene/ferrocenium coupled to a commercial graphite SPEs. In addition, the CNO/GRT SPE can detect dopamine in the concentration range of 10.0-99.9 µM with a limit of detection of 0.92 µM (N = 3). They exhibit a higher analytical sensitivity than the commercial graphite-based SPE, with a 4-fold improvement observed. These results open up the possibility of using high-performing CNO-based SPEs for electrochemical applications including sensors, battery electrodes and electrocatalysis.

Nature inspired poly (dopamine quinone -vanadyl) as new modifier for voltammetric determination of uric acid

The preparation of a novel polymer (poly(dopamine quinone-vanadyl) (polyDQV)) bearing dopaminequinone and VO^IV redox groups is described. PolyDQV was characterized using field emission scanning electron microscopy (FESEM), energy dispersive x-ray spectroscopy, x-ray photoelectron spectroscopy (XPS), Fourier transform infra-red (FTIR) spectroscopy, UV-Vis spectroscopy as well as electrochemical methods such as differential pulse voltammetry, cyclic voltammetry, and electrochemical impedance spectroscopy (EIS). The electrocatalytic activity of polyDQV was studied toward electrooxidation of uric acid using differential pulse voltammetry as well as cyclic voltammetry. PolyDQV presents interesting electrocatalytic activity toward UA oxidation in phosphate buffer solution (0.1 M, pH 2) to a well-defined oxidation peak at 0.65 V (vs. Ag/AgCl). The polyDQV-modified carbon paste electrode (CPE/polyDQV) presents a precise linear signal-concentration relationship in the ranges of 0.3-5 μM and 5 to 200 μM with a detection limit (S/N = 3) of 0.02 μM. The %RSD values for ten replicate measurements of 0.5 and 50 μM UA were 1.8 and 3%, respectively, indicating good repeatability of analytical signals. Appropriate recovery values (in the range 96 to 103%) and good selectivity for UA over common coexisting species (such as ascorbic acid and dopamine) exhibit that CPE/polyDQV is a promising novel platform for sensing UA in human blood serum and urine samples. Graphical abstract.

Customized In Situ Functionalization of Nanodiamonds with Nanoparticles for Composite Carbon-Paste Electrodes

The incorporation of nanomaterials on (bio)sensors based on composite materials has led to important advances in the analytical chemistry field due to the extraordinary properties that these materials offer. Nanodiamonds (NDs) are a novel type of material that has raised much attention, as they have the possibility of being produced on a large scale by relatively inexpensive synthetic methodologies. Moreover, NDs can present some other interesting features, such as fluorescence, due to surface functionalization and proved biocompatibility, which makes them suitable for biomedical applications. In addition, NDs can be customized with metallic nanoparticles (NPs), such as silver or gold, in order to combine the features of both. Raw NDs were used as modifiers of sensors due to the electrocatalytic effect of the sp² and oxygenated species present on their surface. The aim of this research work is evaluating the applicability of NDs modified with silver (Ag@NDs) and gold (Au@NDs) nanoparticles for the development of a suitable (bio)sensing platform. A complete morphological and electrochemical characterization as a function of the prepared nanocomposite composition was performed in order to improve the electroanalytical properties of the developed (bio)sensors. In the present work, the optimal composition for Au@NDs present on the nanocomposite matrix is 3.5% and the one for Ag@NDs is 1%. Good results were obtained in the evaluation of the optimal composition towards hydrogen peroxide and glucose as a model analyte using a (bio)sensor based on graphite-epoxy-Ag@NDs (17:82:1).

Graphene Oxide Bulk-Modified Screen-Printed Electrodes Provide Beneficial Electroanalytical Sensing Capabilities

We demonstrate a facile methodology for the mass production of graphene oxide (GO) bulk-modified screen-printed electrodes (GO-SPEs) that are economical, highly reproducible and provide analytically useful outputs. Through fabricating GO-SPEs with varying percentage mass incorporations (2.5%, 5%, 7.5% and 10%) of GO, an electrocatalytic effect towards the chosen electroanalytical probes is observed, which increases with greater GO incorporated compared to bare/graphite SPEs. The optimum mass ratio of 10% GO to 90% carbon ink produces an electroanalytical signal towards dopamine (DA) and uric acid (UA) which is ca. ×10 greater in magnitude than that achievable at a bare/unmodified graphite SPE. Furthermore, 10% GO-SPEs exhibit a competitively low limit of detection (3σ) towards DA at ca. 81 nM, which is superior to that of a bare/unmodified graphite SPE at ca. 780 nM. The improved analytical response is attributed to the large number of oxygenated species inhabiting the edge and defect sites of the GO nanosheets, which are able to exhibit electrocatalytic responses towards inner-sphere electrochemical analytes. Our reported methodology is simple, scalable, and cost effective for the fabrication of GO-SPEs that display highly competitive LODs and are of significant interest for use in commercial and medicinal applications.

Developing a screen-printed graphite-polyurethane composite electrode modified with gold nanoparticles for the voltammetric determination of dopamine

A screen-printed electrode (SPGPUE) was prepared with graphite-polyurethane composite ink containing gold nanoparticles (AuNPs), resulting in a screen-printed graphite-polyurethane composite electrode modified with gold nanoparticles (SPGPUE-AuNPs). Gold nanoparticles were prepared by the citrate method and extracted from the water medium since polyurethane is not compatible with humidity. After extraction to chloroform, they were characterized via transmission electron microscopy (TEM). The presence of gold on the SPGPUE-AuNP surface was confirmed via SEM and EDX analyses, while thermogravimetry revealed the presence of approximately 3.0% (m/m) gold in the composite. An electrochemical pretreatment in 0.10 mol L-1 phosphate buffer (pH 7.0) with successive cycling between -1.0 V and 1.0 V (vs. pseudo-Ag/AgCl) under a scan rate of 200 mV s-1 and 150 cycles was required in order to provide a suitable electrochemical response for the voltammetric determination of dopamine. After the optimization of the parameters of differential pulse voltammetry (DPV), an analytical curve was obtained within a linear dynamic range of 0.40-60.0 μmol L-1 and detection limit (LOD) of 1.55 ×10-8 mol L-1 for dopamine at the SPGPUE-AuNP. A non-modified SPGPUE was used for comparison and a linear range was obtained between 2.0 and 10 μmol L-1 with an LOD of 2.94 × 10-7 mol L-1. During the dopamine determination in cerebrospinal synthetic fluid (CSF), recoveries between 89.3 and 103% were achieved. There were no significant interferences from ascorbic acid and uric acid, but some from epinephrine due to the structural similarity.

A composite film prepared from titanium carbide Ti3C2Tx (MXene) and gold nanoparticles for voltammetric determination of uric acid and folic acid

In this study, a solution-processing based galvanic deposition approach is described for in-situ deposition of gold nanoparticles (AuNP) on delaminated titanium Ti₃C₂T_x nanosheets under ultrasonication. The nanocomposite (AuNP@Ti₃C₂T_x) was placed on a glassy carbon electrode (GCE) and then applied to electrochemically with label-free, and simultaneously sense uric acid (UA), and folic acid (FA) at physiological pH. The modified GCE has attractive figures of merit: (i) The working potentials for UA and AA are well separated (+0.35 V and 0.70 V vs. Ag|AgCl); (ii) wide linear responses (from 0.03-1520 μM for UA and from 0.02-3580 μM for FA; (iii) good electrochemical sensitivities for both UA and FA (0.53 and 0.494 μAμM^-1.cm^-2, respectively), and (iv) detection limits of 11.5 nM (UA) and 6.20 nM (FA). The electrode exhibited good repeatability (RSD = 4.4%), acceptable reproducibility (RSD = 4.1%), and excellent stability (91.8% over one-month storage). The method was applied to analyze spiked serum samples, and modified GCE is shown appreciable recoveries (97.1-98.8% and 96.8-98.0% for UA, and FA, respectively). Graphical abstractA photograph (top left) of colloidal suspension of gold nanoparticles (AuNPs). They were grown on the delaminated titanium carbide Ti₃C₂T_x MXene nanosheet via galvanic displacement deposition method, and their corresponding a low-resolution transmission electron microscopy micrograph (top right) of AuNP@Ti₃C₂T_x. The graphical representation of AuNP@Ti₃C₂T_x drop-casted on glassy carbon electrode (GCE) (bottom left), and their voltammetric measurement were applied in the presence of both uric acid and folic acid with increasing the concentration of both analytes (bottom right).

Nanomaterials for Healthcare Biosensing Applications

In recent years, an increasing number of nanomaterials have been explored for their applications in biomedical diagnostics, making their applications in healthcare biosensing a rapidly evolving field. Nanomaterials introduce versatility to the sensing platforms and may even allow mobility between different detection mechanisms. The prospect of a combination of different nanomaterials allows an exploitation of their synergistic additive and novel properties for sensor development. This paper covers more than 290 research works since 2015, elaborating the diverse roles played by various nanomaterials in the biosensing field. Hence, we provide a comprehensive review of the healthcare sensing applications of nanomaterials, covering carbon allotrope-based, inorganic, and organic nanomaterials. These sensing systems are able to detect a wide variety of clinically relevant molecules, like nucleic acids, viruses, bacteria, cancer antigens, pharmaceuticals and narcotic drugs, toxins, contaminants, as well as entire cells in various sensing media, ranging from buffers to more complex environments such as urine, blood or sputum. Thus, the latest advancements reviewed in this paper hold tremendous potential for the application of nanomaterials in the early screening of diseases and point-of-care testing.